Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time.
Adolescent
Adult
Asthma
/ diagnosis
Cohort Studies
Cough
/ diagnosis
Dyspnea
/ epidemiology
Female
Forced Expiratory Volume
Humans
Lung Diseases
/ diagnosis
Lung Neoplasms
/ diagnosis
Male
Middle Aged
Norway
/ epidemiology
Pulmonary Disease, Chronic Obstructive
/ diagnosis
Respiration Disorders
/ diagnosis
Respiratory Sounds
Risk Factors
Young Adult
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
03
2021
accepted:
09
11
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
5
1
2022
Statut:
epublish
Résumé
This study determined the association between respiratory symptoms and death from respiratory causes over a period of 45 years. In four cohorts of random samples of Norwegian populations with 103,881 participants, 43,731 persons had died per 31 December 2016. In total, 5,949 (14%) had died from respiratory diseases; 2,442 (41%) from lung cancer, 1,717 (29%) chronic obstructive pulmonary disease (COPD), 1,348 (23%) pneumonia, 119 (2%) asthma, 147 (2%) interstitial lung disease and 176 (3%) other pulmonary diseases. Compared with persons without respiratory symptoms the multivariable adjusted hazard ratio (HR) for lung cancer deaths increased with score of breathlessness on effort and cough and phlegm, being 2.6 (95% CI 2.1-3.2) for breathlessness score 3 and 2.1 (95% CI 1.7-2.5) for cough and phlegm score 5. The HR of COPD death was 6.4 (95% CI 5.4-7.7) for breathlessness score 3 and 3.0 (2.4-3.6) for cough and phlegm score 5. Attacks of breathlessness and wheeze score 2 had a HR of 1.6 (1.4-1.9) for COPD death. The risk of pneumonia deaths increased also with higher breathlessness on effort score, but not with higher cough and phlegm score, except for score 2 with HR 1.5 (1.2-1.8). In this study with >2.4 million person-years at risk, a positive association was observed between scores of respiratory symptoms and deaths due to COPD and lung cancer. Respiratory symptoms are thus important risk factors, which should be followed thoroughly by health care practitioners for the benefit of public health.
Identifiants
pubmed: 34807953
doi: 10.1371/journal.pone.0260416
pii: PONE-D-21-08054
pmc: PMC8608323
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0260416Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: RN reports grants and personal fees from AstraZeneca, grants from GlaxoSmithKline, grants from Boehringer Ingelheim, outside the submitted work. All other authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Eur Respir J. 2019 Sep 19;54(3):
pubmed: 31537654
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
Clin Respir J. 2008 Oct;2 Suppl 1:10-25
pubmed: 20298346
Arch Public Health. 2020 May 25;78:46
pubmed: 32509303
Eur Respir J. 2004 Apr;23(4):589-94
pubmed: 15083759
Lakartidningen. 1970 Jan 7;67(2):145-9
pubmed: 5415737
COPD. 2014 Feb;11(1):59-80
pubmed: 23875716
Respir Med. 2020 Aug - Sep;170:106060
pubmed: 32843179
Eur Respir J. 2019 Sep 19;54(3):
pubmed: 31248954
Clin Respir J. 2008 Oct;2 Suppl 1:53-8
pubmed: 20298350
Scand J Respir Dis. 1979 Oct;60(5):275-85
pubmed: 316574
Tidsskr Nor Laegeforen. 2015 May 05;135(8):768-70
pubmed: 25947599
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
Sci Rep. 2021 Feb 25;11(1):4539
pubmed: 33633205
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Int Stat Rev. 2017 Aug;85(2):185-203
pubmed: 29307954
Eur Respir J. 2005 Apr;25(4):618-25
pubmed: 15802334
Am J Epidemiol. 1989 Jun;129(6):1157-69
pubmed: 2729254
Respir Med. 2012 Apr;106(4):515-21
pubmed: 22100536
Thorax. 2006 Nov;61(11):951-6
pubmed: 16809414
Br J Gen Pract. 2020 Mar 26;70(693):e264-e273
pubmed: 32041768
Eur Respir J. 2015 Apr;45(4):953-61
pubmed: 25359344
Am J Epidemiol. 1997 Jan 1;145(1):72-80
pubmed: 8982025
Int J Epidemiol. 1998 Dec;27(6):962-9
pubmed: 10024189
Int J Tuberc Lung Dis. 2000 Jan;4(1):83-90
pubmed: 10654649
Am J Public Health. 2016 Aug;106(8):1422-6
pubmed: 27196650
J Intern Med. 2006 Oct;260(4):332-42
pubmed: 16961670
Eur Respir J. 1991 Mar;4(3):273-8
pubmed: 1864342
COPD. 2010 Jun;7(3):179-85
pubmed: 20486816
Scand J Work Environ Health. 1990 Jun;16(3):195-202
pubmed: 2382122
BMC Pulm Med. 2018 Sep 12;18(1):152
pubmed: 30208969